These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Olanzapine for the prevention and treatment of cancer-related nausea and vomiting in adults. Sutherland A; Naessens K; Plugge E; Ware L; Head K; Burton MJ; Wee B Cochrane Database Syst Rev; 2018 Sep; 9(9):CD012555. PubMed ID: 30246876 [TBL] [Abstract][Full Text] [Related]
45. Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy. Smith LA; Azariah F; Lavender VT; Stoner NS; Bettiol S Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD009464. PubMed ID: 26561338 [TBL] [Abstract][Full Text] [Related]
46. Early versus deferred standard androgen suppression therapy for advanced hormone-sensitive prostate cancer. Kunath F; Jensen K; Pinart M; Kahlmeyer A; Schmidt S; Price CL; Lieb V; Dahm P Cochrane Database Syst Rev; 2019 Jun; 6(6):CD003506. PubMed ID: 31194882 [TBL] [Abstract][Full Text] [Related]
47. Which patients with metastatic hormone-sensitive prostate cancer benefit from docetaxel: a systematic review and meta-analysis of individual participant data from randomised trials. Vale CL; Fisher DJ; Godolphin PJ; Rydzewska LH; Boher JM; Burdett S; Chen YH; Clarke NW; Fizazi K; Gravis G; James ND; Liu G; Matheson D; Murphy L; Oldroyd RE; Parmar MKB; Rogozinska E; Sfumato P; Sweeney CJ; Sydes MR; Tombal B; White IR; Tierney JF; Lancet Oncol; 2023 Jul; 24(7):783-797. PubMed ID: 37414011 [TBL] [Abstract][Full Text] [Related]
48. Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials. Prostate Cancer Trialists' Collaborative Group. Lancet; 2000 Apr; 355(9214):1491-8. PubMed ID: 10801170 [TBL] [Abstract][Full Text] [Related]
57. Nilutamide approved for metastatic prostate cancer. Am J Health Syst Pharm; 1996 Dec; 53(23):2784. PubMed ID: 8957341 [No Abstract] [Full Text] [Related]
58. Nilutamide response after flutamide failure in post-orchiectomy progressive prostate cancer. Eastham JA; Sartor O J Urol; 1998 Mar; 159(3):990. PubMed ID: 9474206 [No Abstract] [Full Text] [Related]
59. Burden of Metastatic Castrate Naive Prostate Cancer Patients, to Identify Men More Likely to Benefit from Early Docetaxel: Further Analyses of CHAARTED and GETUG-AFU15 Studies. Gravis G; Boher JM; Chen YH; Liu G; Fizazi K; Carducci MA; Oudard S; Joly F; Jarrard DM; Soulie M; Eisenberger MJ; Habibian M; Dreicer R; Garcia JA; Hussain MHM; Kohli M; Vogelzang NJ; Picus J; DiPaola R; Sweeney C Eur Urol; 2018 Jun; 73(6):847-855. PubMed ID: 29475737 [TBL] [Abstract][Full Text] [Related]
60. Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults. Hristovska AM; Duch P; Allingstrup M; Afshari A Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012763. PubMed ID: 28806470 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]